BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $269,000 | -2.9% | 22,750 | +8.1% | 0.01% | +18.2% |
| Q2 2022 | $277,000 | -60.9% | 21,050 | -37.9% | 0.01% | -57.7% |
| Q1 2022 | $709,000 | -5.3% | 33,903 | -7.9% | 0.03% | -3.7% |
| Q4 2021 | $749,000 | -4.1% | 36,827 | +43.1% | 0.03% | -18.2% |
| Q3 2021 | $781,000 | +18.0% | 25,727 | +12.9% | 0.03% | +17.9% |
| Q2 2021 | $662,000 | -72.4% | 22,796 | -59.0% | 0.03% | -71.7% |
| Q1 2021 | $2,399,000 | -10.2% | 55,596 | -3.9% | 0.10% | -2.9% |
| Q4 2020 | $2,672,000 | +5.7% | 57,847 | -0.8% | 0.10% | -14.3% |
| Q3 2020 | $2,528,000 | +141.7% | 58,303 | +195.5% | 0.12% | +101.7% |
| Q2 2020 | $1,046,000 | – | 19,730 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |